Neuland Laboratories appoints Saharsh Davuluri as CEO to lead its $30m peptide facility expansion, targeting growth in ...
Neuland Laboratories, a global contract development and manufacturing organization (CDMO) specialising in complex APIs, has today announced a leadership change. Saharsh Davuluri will assume the role ...
At DCAT Week 2026, Contract Pharma spoke to Neuland's incoming CEO, Saharsh Davuluri, about the company's journey in peptide ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered ...
Shares of Neuland Laboratories jumped as much as 10% to their 52-week high of Rs 19,599 in morning deals on Monday, November 10, after the company reported a robust performance for the quarter ended ...
New Delhi, Dec 12 (PTI) Financial services company Capital Group on Thursday exited Neuland Laboratories by selling 3.77 per cent stake in the company for Rs 756 crore through an open market ...
Neuland Laboratories Limited, a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located ...
The average one-year price target for Neuland Laboratories (NSEI:NEULANDLAB) has been revised to ₹ 21,022.20 / share. This is an increase of 21.41% from the prior estimate of ₹ 17,314.50 dated ...
- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- ...
Neuland appoints Saharsh Davuluri as CEO & MD to lead the next phase of CDMO expansion: Our Bureau, Bengaluru Thursday, April 2, 2026, 12:50 Hrs [IST] Neuland Laboratories, a glob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results